Lemaitre Vascular (LMAT) Tops Q4 EPS by 10c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
LeMaitre Vascular Announces Q4 2018 Financial Results
February 19, 2019 4:05 PM ESTBURLINGTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q4 2018 results, provided guidance, announced a 21% dividend increase to $0.085/share and announced a share repurchase program.
Q4 2018 Results
Record sales of $28.4mm, +9% (+6% organic) vs. Q4 2017Operating income of $7.2mm vs. $6.3mm, +14%Net income of $6.0mm vs. $4.3mm, +41%Earnings of $0.30 per diluted share vs. $0.21, +41%EBITDA of $8.3mm vs. $7.4mm, +13%    ÂQ4 2018 sales were driven by embolectomy catheters,... More
